Wird geladen...
Hepatitis C virus: A time for decisions. Who should be treated and when?
Cirrhosis is the most important risk factor for hepatocellular carcinoma (HCC) regardless of the etiology of cirrhosis. Compared to individuals who are anti-hepatitis C virus (HCV) seronegative, anti-HCV seropositive individuals have a greater mortality from both hepatic as well as nonhepatic diseas...
Gespeichert in:
| Veröffentlicht in: | World J Gastrointest Pharmacol Ther |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734952/ https://ncbi.nlm.nih.gov/pubmed/26855810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v7.i1.33 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|